A slow-release dexamethasone implant for cancer-associated retinopathy.

Leandro J Chaves,Marina L de Albuquerque, Amanda Schnorr,Francyne Cyrino, Maria Lúcia Habib,André Messias,Zelia M Correa,Rodrigo Jorge

Arquivos brasileiros de oftalmologia（2022）

引用 1|浏览10

暂无评分

摘要

This case report aims to show the anatomical and functional results of a patient diagnosed as having cancer-associated retinopathy treated with a controlled-release dexamethasone implant (Ozurdex). Anatomical outcomes were assessed using spectral domain optical coherence tomography; and functional outcomes, by measuring visual acuity, microperimetry, and mutifocal electroretinography. The follow-up period was 1 year.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要